SEC Comment Letter for Medline (MDLN) — Feb 12, 2026
Medline Inc.
Date: Feb. 12, 2026 · CIK: 0002046386 · Accession: 0000000000-26-001524
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> February 12, 2026 James Boyle Chief Executive Officer Medline Inc. 3 Lakes Drive Northfield, IL 60093 Re: Medline Inc. Draft Registration Statement on Form S-1 Submitted February 09, 2026 CIK No. 0002046386 Dear James Boyle: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Katharine Thompson </TEXT> </DOCUMENT>